Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα.
about
New insights into the biology of tissue factor pathway inhibitorBiology of tissue factor pathway inhibitor.Platelets contain tissue factor pathway inhibitor-2 derived from megakaryocytes and inhibits fibrinolysis.Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulationPlatelet-Derived Short-Chain Polyphosphates Enhance the Inactivation of Tissue Factor Pathway Inhibitor by Activated Coagulation Factor XI.Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.Platelets: Context-Dependent Vascular Protectors or Mediators of Disease.Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation.Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.The hemostatic role of factor XI.Rethinking events in the haemostatic process: role of factor V and TFPI.New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice.Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.Factor V, tissue factor pathway inhibitor, and east Texas bleeding disorderThe C-terminus of tissue factor pathway inhibitor-α inhibits factor V activation by protecting the Arg1545 cleavage site.Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.Heparin, coumarin, protein C, antithrombin, fibrinolysis and other clotting related resistances: old and new concepts in blood coagulation.Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.Thrombotic and Hemorrhagic Conditions Due to a Gain of Function of Coagulation Proteins: A Special Type of Clotting Disorders.Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength.Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S.
P2860
Q26865048-6DE247E5-4C98-4E73-BFB6-BAAD64F21202Q33585249-D047D6E8-3DE0-4122-84B2-E0661CEDF17BQ34467715-C9DAD8A4-4AA2-4865-8106-8695C26295A1Q35227861-777FECFE-8707-46C4-8775-D934CAB03B59Q36169665-6D6F9E1A-59B4-4D53-9789-DEF0690BB85CQ36403196-E22E6B5E-054C-4EF2-B3A2-CCE2402F7715Q37007335-45CCC9CA-7F5C-4B7E-A77A-4FF6884C1A0AQ37276726-68AE1509-3C0F-433D-B409-81B05150291DQ38663583-633022EF-9E69-4AB9-8D72-0D13782792C4Q38830523-B5291FF5-8E9C-4379-AA64-855BFA8D620EQ38840382-F3FD6548-9E76-4E91-993B-DDE33867E944Q38894147-98DEEFC9-3620-4E74-838F-C4ED92CF0764Q39157494-30733ADF-2257-435E-9EE6-B8DA71B35CD0Q41936652-F27AFE76-A835-4770-B3B5-65CE836E5FE1Q42572915-8F4CBC1F-7ED2-4624-8F87-8431A2F38429Q46466521-6E723CDD-F8D7-4278-A5EB-7A001F6DBAE0Q47447917-E08C1A07-B82D-495C-8C6B-FEE7174FA7C3Q47612100-0435E06D-A7BD-4F1C-B1D5-B794887D069EQ47900623-76503DC2-0AF6-4045-B3F2-438F7E15877FQ47994202-6DADAFE8-2F06-4E14-87A6-584A8EA7828CQ49922306-916F89EA-B957-4A06-BBD6-CAEFD559C045Q55447752-27C58C08-0619-4DB5-8A3F-19FE85DDC8FA
P2860
Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Coagulation factor V
@nl
Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα.
@en
type
label
Coagulation factor V
@nl
Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα.
@en
prefLabel
Coagulation factor V
@nl
Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα.
@en
P2093
P2860
P356
P1476
Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIα.
@en
P2093
Björn Dahlbäck
Dianna M Milewicz
Lisa M Vincent
Ruzica Livaja
Tracy A Bensend
P2860
P304
P356
10.1172/JCI69091
P407
P577
2013-08-27T00:00:00Z